File: //home/govancoz/mail/new/1704813819.M113595P3939322.zacp120.ve.host,S=3880,W=3961
Return-Path: <social@quieromipc.com.mx>
Delivered-To: govancoz@zacp120.ve.host
Received: from zacp120.ve.host
by zacp120.ve.host with LMTP
id OJz4BftknWX6GzwAvcbEzQ
(envelope-from <social@quieromipc.com.mx>)
for <govancoz@zacp120.ve.host>; Tue, 09 Jan 2024 17:23:39 +0200
Return-path: <social@quieromipc.com.mx>
Envelope-to: candice@govan.co.za
Delivery-date: Tue, 09 Jan 2024 17:23:39 +0200
Received: from [74.208.107.77] (port=48371 helo=compassionate-hopper.74-208-107-77.plesk.page)
by zacp120.ve.host with esmtps (TLS1.3) tls TLS_AES_256_GCM_SHA384
(Exim 4.96.2)
(envelope-from <social@quieromipc.com.mx>)
id 1rMr9t-008wcD-22
for candice@govan.co.za;
Mon, 08 Jan 2024 17:03:20 +0200
Received: from [197.232.82.118] (unknown [197.232.133.192])
by compassionate-hopper.74-208-107-77.plesk.page (Postfix) with ESMTPA id D13ACBA4FD;
Mon, 8 Jan 2024 09:42:07 +0000 (UTC)
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=quieromipc.com.mx;
s=default; t=1704706944;
bh=LJ3nIJTN2V/V3cii9ZU7cLs6koAJT5pTc2jQAgvfR/E=; h=Subject:To:From;
b=J1OuwhuVhi/+y9ewX27GwVuxiAL2aDEnkgWOcQWMMbOpBHK0ujQfma5A+jLWhKzkN
N8e9Yn1VU26pSbT5RopwsExcJx42NE/rLI1617jehu5p3WlQjVFW0uAexPNuxb10qF
nU0xWe4ifJN7g2KlzNfacbhfOl3PkOVrGwQLaUio=
Authentication-Results: compassionate-hopper.74-208-107-77.plesk.page;
spf=pass (sender IP is 197.232.133.192) smtp.mailfrom=social@quieromipc.com.mx smtp.helo=[197.232.82.118]
Received-SPF: pass (compassionate-hopper.74-208-107-77.plesk.page: connection is authenticated)
Content-Type: multipart/alternative; boundary="===============1039307912=="
MIME-Version: 1.0
Subject: WE INTEND TO PARTNER WITH YOU.
To: Recipients <social@quieromipc.com.mx>
From: "Dr. Yasunobu Otsuga" <social@quieromipc.com.mx>
Date: Mon, 08 Jan 2024 12:41:51 +0300
Reply-To: dr.yasunobu1@gmail.com
You will not see this in a MIME-aware mail reader.
--===============1039307912==
Content-Type: text/plain; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
Hello
Daito Pharma Co., Ltd. is a Japan-based manufacturing pharmaceutical comp=
any engaged in the pharmaceutical ingredients and formulation business . Ar=
e you interested in working with us to be our company representative in you=
r country, The Republic of South Africa, for a period of five years contrac=
t? Please Kindly let us know if you are interested while I direct you to m=
y working company email address
Apologies for using my personal email address for these proposals. However=
, The reason was to get an immediate notification from you once you respond=
ed.
Best regards,
Dr. Yasunobu Otsuga
President & CEO
Daito Pharmaceutical Co., Ltd.
326 Yokamachi, Toyama City, Toyama Prefecture 939-8567
--===============1039307912==
Content-Type: text/html; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
<HTML><head><meta http-equiv=3D"Content-Type" content=3D"text/html; charset=
=3Diso-8859-1"/></head><BODY><P>Hello</P>
<P>Daito Pharma Co., Ltd. is a Japan-based manufacturing pharmaceutic=
al company engaged in the pharmaceutical ingredients and formulation busine=
ss . Are you interested in working with us to be our company representative=
in your country, The Republic of South Africa, for a period of five years =
contract? Please Kindly let us know if you are interested while I dir=
ect you to my working company email address</P>
<P>Apologies for using my personal email address for these proposals. Howev=
er, The reason was to get an immediate notification from you once you respo=
nded.</P>
<P>Best regards,<BR>Dr. Yasunobu Otsuga<BR>President & CEO<BR>Dai=
to Pharmaceutical Co., Ltd.<BR>326 Yokamachi, Toyama City, Toyama Prefectur=
e 939-8567</P></BODY></HTML>
--===============1039307912==--